Asclepius TriAgenics, LP is a venture capital fund based in Naples, Florida. According to its most recent Form D, filed Sep 12, 2025, it has sold $3,625,000 of interests to 20 investors since its first sale in Jul 2025. The minimum investment it accepts from an outside investor is $250,000. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(b), which does not permit general solicitation. Based on its first sale date and the amount raised, AltMountain classifies it as an emerging manager. Related persons named in the filing include Asclepius Ventures LLC; David Jahns.
- Total raised
- $3,625,000Cumulative sales reported on Form D
- Investors
- 20
- First sale
- Jul 8, 2025
- Minimum investment
- $250,000
- Who can invest
- Accredited investorsSection 3(c)(1): up to 100 beneficial owners
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Asclepius Ventures LLC; David Jahns
- Latest Form D
- Sep 12, 2025
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about Asclepius TriAgenics, LP
What is the minimum investment for Asclepius TriAgenics, LP?
According to its latest Form D, filed Sep 12, 2025, the minimum investment Asclepius TriAgenics, LP accepts from an outside investor is $250,000.
Who can invest in Asclepius TriAgenics, LP?
Asclepius TriAgenics, LP is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(b), which does not allow general advertising.
How much has Asclepius TriAgenics, LP raised?
Asclepius TriAgenics, LP reports $3,625,000 sold from 20 investors on its Form D filed Sep 12, 2025. This is cumulative sales since the offering began, not current assets or performance.
Where is Asclepius TriAgenics, LP based?
Asclepius TriAgenics, LP is based in Naples, Florida.
When did Asclepius TriAgenics, LP launch?
Asclepius TriAgenics, LP reports its first sale in Jul 2025, which makes it an emerging manager by AltMountain's definition (first sale in 2021 or later and under $50 million raised).
Size compared with every venture capital fund
Raised more than 63% of the 585 venture capital funds based in Florida, and more than 78% of all 15,180 that report sales.